Seres Therapeutics, Inc. (MCRB)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EST
After hours:
Currency in USD
Valuation measures4
| Market cap (intra-day) | 685.25M |
| Enterprise value | 528.29M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 37.98 |
| Price/book (mrq) | 10.14 |
| Enterprise value/revenue | 36.58 |
| Enterprise value/EBITDA | -2.40 |
Trading information
Stock price history
| Beta (5Y monthly) | 2.76 |
| 52-week change 3 | -33.69% |
| S&P500 52-week change 3 | -9.85% |
| 52-week high 3 | 9.49 |
| 52-week low 3 | 2.50 |
| 50-day moving average 3 | 5.94 |
| 200-day moving average 3 | 5.32 |
Share statistics
| Avg vol (3-month) 3 | 787.05k |
| Avg vol (10-day) 3 | 667.81k |
| Shares outstanding 5 | 124.59M |
| Implied shares outstanding 6 | N/A |
| Float 8 | 92.98M |
| % held by insiders 1 | 6.67% |
| % held by institutions 1 | 85.93% |
| Shares short (12 Jan 2023) 4 | 6.57M |
| Short ratio (12 Jan 2023) 4 | 8.62 |
| Short % of float (12 Jan 2023) 4 | 7.42% |
| Short % of shares outstanding (12 Jan 2023) 4 | 5.27% |
| Shares short (prior month 14 Dec 2022) 4 | 4.74M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2021 |
| Most-recent quarter (mrq) | 29 Sept 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | -1,701.92% |
Management effectiveness
| Return on assets (ttm) | -40.18% |
| Return on equity (ttm) | -190.17% |
Income statement
| Revenue (ttm) | 13.37M |
| Revenue per share (ttm) | 0.13 |
| Quarterly revenue growth (yoy) | -97.30% |
| Gross profit (ttm) | 3.04M |
| EBITDA | -221.06M |
| Net income avi to common (ttm) | -231.36M |
| Diluted EPS (ttm) | -0.94 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 233M |
| Total cash per share (mrq) | 1.87 |
| Total debt (mrq) | 76.04M |
| Total debt/equity (mrq) | 112.51 |
| Current ratio (mrq) | 3.03 |
| Book value per share (mrq) | 0.54 |
Cash flow statement
| Operating cash flow (ttm) | -227.79M |
| Levered free cash flow (ttm) | -129.89M |
© 2023 Yahoo. All rights reserved.
